• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TXNDC5高表达预示肾细胞癌预后不良。

High TXNDC5 expression predicts poor prognosis in renal cell carcinoma.

作者信息

Mo Ren, Peng Jingtao, Xiao Jiantao, Ma Jian, Li Weiguo, Wang Jing, Ruan Yuan, Ma Shaofei, Hong Yan, Wang Chenji, Gao Kun, Fan Jie

机构信息

Department of Urology, Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200080, China.

Department of Urology, Inner Mongolia Autonomous Region Peoples Hospital, Hohhot, 010017, Inner Mongolia, China.

出版信息

Tumour Biol. 2016 Jul;37(7):9797-806. doi: 10.1007/s13277-016-4891-7. Epub 2016 Jan 26.

DOI:10.1007/s13277-016-4891-7
PMID:26810069
Abstract

Clear cell renal cell carcinoma (ccRCC) is the most common primary kidney cancer in adults, and the identification of biomarkers involved in the pathogenesis and prognosis of ccRCC is crucial for early diagnosis and anticancer treatment. In this study, we demonstrate that thioredoxin domain-containing protein 5 (TXNDC5) expression is markedly upregulated in ccRCC tissues in comparison with adjacent non-cancerous tissues through quantitative RT-PCR, Western blotting, and immunohistochemical analyses. Importantly, TXNDC5 expression is negatively correlated with the overall survival of patients. Knockdown of TXNDC5 by siRNAs inhibits the cell growth, migration, and invasion of ccRCC cells as well as sensitizes ccRCC cells to chemotherapeutic drugs, such as Camptothecin and 5-Fluorouracil. Moreover, we used complementary DNA (cDNA) microarray analyses to explore the underlying molecular mechanisms of TXNDC5 in the pathogenesis of ccRCC. We demonstrate that knockdown of TXNDC5 affects the messenger RNA (mRNA) and protein levels of numerous important genes associated with tumorigenesis. In summary, our findings indicate that TXNDC5 performs an essential function in ccRCC pathogenesis and can serve as a novel prognostic marker of ccRCC.

摘要

透明细胞肾细胞癌(ccRCC)是成人中最常见的原发性肾癌,鉴定参与ccRCC发病机制和预后的生物标志物对于早期诊断和抗癌治疗至关重要。在本研究中,我们通过定量逆转录聚合酶链反应(RT-PCR)、蛋白质免疫印迹和免疫组织化学分析证明,与相邻的非癌组织相比,含硫氧还蛋白结构域蛋白5(TXNDC5)在ccRCC组织中的表达明显上调。重要的是,TXNDC5表达与患者的总生存期呈负相关。通过小干扰RNA(siRNA)敲低TXNDC5可抑制ccRCC细胞的生长、迁移和侵袭,并使ccRCC细胞对化疗药物如喜树碱和5-氟尿嘧啶敏感。此外,我们使用互补DNA(cDNA)微阵列分析来探索TXNDC5在ccRCC发病机制中的潜在分子机制。我们证明,敲低TXNDC5会影响许多与肿瘤发生相关的重要基因的信使核糖核酸(mRNA)和蛋白质水平。总之,我们的研究结果表明,TXNDC5在ccRCC发病机制中发挥着重要作用,可作为ccRCC的一种新的预后标志物。

相似文献

1
High TXNDC5 expression predicts poor prognosis in renal cell carcinoma.TXNDC5高表达预示肾细胞癌预后不良。
Tumour Biol. 2016 Jul;37(7):9797-806. doi: 10.1007/s13277-016-4891-7. Epub 2016 Jan 26.
2
PLAGL1 (ZAC1/LOT1) Expression in Clear Cell Renal Cell Carcinoma: Correlations with Disease Progression and Unfavorable Prognosis.PLAGL1(ZAC1/LOT1)在透明细胞肾细胞癌中的表达:与疾病进展及不良预后的相关性
Anticancer Res. 2016 Feb;36(2):617-24.
3
Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO/EPO-R system and hypoxia-related proteins.透明细胞肾细胞癌非转移阶段的肿瘤生物学;硬脂酰去饱和酶-1、促红细胞生成素/促红细胞生成素受体系统及缺氧相关蛋白的过表达
Tumour Biol. 2016 Oct;37(10):13581-13593. doi: 10.1007/s13277-016-5279-4. Epub 2016 Jul 28.
4
Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.胎盘特异性8的过表达与透明细胞肾细胞癌的恶性进展及不良预后相关。
Int Urol Nephrol. 2017 Jul;49(7):1165-1176. doi: 10.1007/s11255-017-1578-y. Epub 2017 Mar 27.
5
Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.Livin基因沉默可诱导细胞凋亡和自噬性细胞死亡,增强肾癌细胞对顺铂的化疗敏感性。
Tumour Biol. 2016 Nov;37(11):15133-15143. doi: 10.1007/s13277-016-5395-1. Epub 2016 Sep 27.
6
LIM and SH3 domain protein 1 (LASP-1) overexpression was associated with aggressive phenotype and poor prognosis in clear cell renal cell cancer.LIM和SH3结构域蛋白1(LASP-1)的过表达与透明细胞肾细胞癌的侵袭性表型及不良预后相关。
PLoS One. 2014 Jun 23;9(6):e100557. doi: 10.1371/journal.pone.0100557. eCollection 2014.
7
Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.α-烯醇化酶是透明细胞肾细胞癌的一种潜在预后标志物。
Clin Exp Metastasis. 2015 Aug;32(6):531-41. doi: 10.1007/s10585-015-9725-2. Epub 2015 Jun 3.
8
Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.生长分化因子9(GDF9)表达降低与人类透明细胞肾细胞癌的侵袭性行为及患者较差的生存率相关。
Anticancer Res. 2014 Nov;34(11):6515-20.
9
Decreased expression of NPRL2 in renal cancer cells is associated with unfavourable pathological, proliferation and apoptotic features.肾癌细胞中NPRL2表达降低与不良的病理、增殖和凋亡特征相关。
Pathol Oncol Res. 2014 Oct;20(4):829-37. doi: 10.1007/s12253-014-9761-2. Epub 2014 May 1.
10
Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.长链非编码RNA LUCAT1通过AKT/GSK-3β信号通路促进肾透明细胞癌的增殖和侵袭。
Cell Physiol Biochem. 2018;48(3):891-904. doi: 10.1159/000491957. Epub 2018 Jul 20.

引用本文的文献

1
Parecoxib Enhances Resveratrol against Human Colorectal Cancer Cells through Akt and TXNDC5 Inhibition and MAPK Regulation.帕瑞昔布增强白藜芦醇对人结直肠癌细胞的作用机制:通过 Akt 和 TXNDC5 抑制及 MAPK 调控。
Nutrients. 2024 Sep 6;16(17):3020. doi: 10.3390/nu16173020.
2
Thioredoxin Domain Containing 5 (TXNDC5): Friend or Foe?含硫氧还蛋白结构域5(TXNDC5):敌还是友?
Curr Issues Mol Biol. 2024 Apr 4;46(4):3134-3163. doi: 10.3390/cimb46040197.
3
The role and mechanism of TXNDC5 in disease progression.TXNDC5 在疾病进展中的作用和机制。

本文引用的文献

1
The role of TXNDC5 in castration-resistant prostate cancer-involvement of androgen receptor signaling pathway.TXNDC5 在去势抵抗性前列腺癌中的作用——涉及雄激素受体信号通路。
Oncogene. 2015 Sep 3;34(36):4735-45. doi: 10.1038/onc.2014.401. Epub 2014 Dec 15.
2
Landmarks in the diagnosis and treatment of renal cell carcinoma.肾细胞癌的诊断和治疗要点。
Nat Rev Urol. 2014 Sep;11(9):517-25. doi: 10.1038/nrurol.2014.194. Epub 2014 Aug 12.
3
Endoplasmic reticulum stress associated responses in cancer.癌症中内质网应激相关反应
Front Immunol. 2024 Apr 2;15:1354952. doi: 10.3389/fimmu.2024.1354952. eCollection 2024.
4
Endoplasmic Reticulum Protein TXNDC5 Interacts with PRDX6 and HSPA9 to Regulate Glutathione Metabolism and Lipid Peroxidation in the Hepatic AML12 Cell Line.内质网蛋白 TXNDC5 与 PRDX6 和 HSPA9 相互作用,调节肝 AML12 细胞系中的谷胱甘肽代谢和脂质过氧化。
Int J Mol Sci. 2023 Dec 5;24(24):17131. doi: 10.3390/ijms242417131.
5
Recognition of immune-related tumor antigens and immune subtypes for mRNA vaccine development in lung adenocarcinoma.识别用于肺腺癌mRNA疫苗开发的免疫相关肿瘤抗原和免疫亚型。
Comput Struct Biotechnol J. 2022 Sep 5;20:5001-5013. doi: 10.1016/j.csbj.2022.08.066. eCollection 2022.
6
The role and mechanism of TXNDC5 in diseases.TXNDC5 在疾病中的作用和机制。
Eur J Med Res. 2022 Aug 8;27(1):145. doi: 10.1186/s40001-022-00770-4.
7
Thioredoxin Domain Containing 5 Suppression Elicits Serum Amyloid A-Containing High-Density Lipoproteins.含硫氧还蛋白结构域5的抑制作用可引发含血清淀粉样蛋白A的高密度脂蛋白。
Biomedicines. 2022 Mar 18;10(3):709. doi: 10.3390/biomedicines10030709.
8
Development and Clinical Validation of a Seven-Gene Prognostic Signature Based on Multiple Machine Learning Algorithms in Kidney Cancer.基于多种机器学习算法的肾癌 7 基因预后签名的建立与临床验证。
Cell Transplant. 2021 Jan-Dec;30:963689720969176. doi: 10.1177/0963689720969176.
9
The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies.肿瘤发生与抗癌治疗中的NRF2、硫氧还蛋白和谷胱甘肽系统
Antioxidants (Basel). 2020 Nov 19;9(11):1151. doi: 10.3390/antiox9111151.
10
Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.肾肿瘤的生物标志物:现状与临床前景
Curr Urol Rep. 2017 Jan;18(1):3. doi: 10.1007/s11934-017-0655-1.
Biochim Biophys Acta. 2014 Oct;1843(10):2143-9. doi: 10.1016/j.bbamcr.2014.01.012. Epub 2014 Jan 16.
4
STAT inhibitors for cancer therapy.用于癌症治疗的信号转导和转录激活因子抑制剂
J Hematol Oncol. 2013 Dec 5;6:90. doi: 10.1186/1756-8722-6-90.
5
Endoplasmic reticulum stress: its role in disease and novel prospects for therapy.内质网应激:其在疾病中的作用及治疗新前景
Scientifica (Cairo). 2012;2012:857516. doi: 10.6064/2012/857516. Epub 2012 Dec 23.
6
TXNDC5 gene polymorphism contributes to increased risk of hepatocellular carcinoma in the Korean male population.TXNDC5 基因多态性增加韩国男性人群罹患肝细胞癌的风险。
Anticancer Res. 2013 Sep;33(9):3983-7.
7
Notch signaling at a glance.一目了然的 Notch 信号通路。
J Cell Sci. 2013 May 15;126(Pt 10):2135-40. doi: 10.1242/jcs.127308. Epub 2013 May 31.
8
Caspase control: protagonists of cancer cell apoptosis.半胱天冬酶调控:癌细胞凋亡的关键因素
Exp Oncol. 2012 Oct;34(3):165-75.
9
Proteostasis regulation at the endoplasmic reticulum: a new perturbation site for targeted cancer therapy.内质网的蛋白稳态调节:靶向癌症治疗的新扰动点。
Cell Res. 2011 Jun;21(6):867-83. doi: 10.1038/cr.2011.75. Epub 2011 May 3.
10
EAU guidelines on renal cell carcinoma: the 2010 update.EAU 指南:肾细胞癌——2010 年更新版。
Eur Urol. 2010 Sep;58(3):398-406. doi: 10.1016/j.eururo.2010.06.032. Epub 2010 Jul 12.